Works matching IS 02780232 AND DT 2022 AND VI 40 AND IP 4

Results: 36

Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 777, doi. 10.1002/hon.3017

By:

Wen, Bingbing;
Zhang, Xiaohan;
Chen, Shiyu;
Fan, Jingchao;
Yang, Sitian;
Cai, Yun;
Wang, Pengcheng;
Zhang, Qiaoxia;
Gu, Qingli;
Du, Xin

Publication type:

Article

The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 678, doi. 10.1002/hon.3007

By:

Gao, Yuyang;
Feng, Xiaoyan;
Song, Wenting;
Li, Hongwen;
Shi, Cunzhen;
Jin, Mengyuan;
Li, Zhaoming;
Zhang, Lei;
Zhang, Mingzhi

Publication type:

Article

Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 724, doi. 10.1002/hon.3015

By:

Wang, Jun;
Dao, Feng‐Ting;
Wang, Yu;
Jiang, Hao;
Xu, Lan‐Ping;
Zhao, Xiao‐Su;
Zhang, Xiao‐Hui;
Liu, Kai‐Yan;
Huang, Xiao‐Jun;
Jiang, Qian;
Qin, Ya‐Zhen

Publication type:

Article

"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 805, doi. 10.1002/hon.2985

By:

Lapierre, Léopoldine;
Syrykh, Charlotte;
Largeaud, Laetitia;
Cabarrou, Bastien;
Filleron, Thomas;
Oberic, Lucie;
Kanoun, Salim;
Coster, Lucie;
Laurent, Camille;
Branco, Benoît;
Gadaud, Noémie;
Récher, Christian;
Brechemier, Delphine;
Balardy, Laurent;
Vergez, François;
Ysebaert, Loïc;
Gauthier, Martin

Publication type:

Article

Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 588, doi. 10.1002/hon.3027

By:

Piñeyroa, Juan A.;
Magnano, Laura;
Rivero, Andrea;
Rivas‐Delgado, Alfredo;
Nadeu, Ferran;
Correa, Juan Gonzalo;
Giné, Eva;
Villamor, Neus;
Filella, Xavier;
Colomer, Dolors;
López, Mònica;
López‐Oreja, Irene;
Costa, Dolors;
Aymerich, Marta;
Beà, Sílvia;
López‐Guillermo, Armando;
Campo, Elías;
Delgado, Julio;
Mozas, Pablo

Publication type:

Article

Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 626, doi. 10.1002/hon.3034

By:

Diamond, Akiva;
Ayyappan, Sabarish;
Cao, Shufen;
Tashtish, Nour;
Boughan, Kirsten;
Cooper, Brenda;
Fu, PingFu;
Caimi, Paolo F.

Publication type:

Article

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031

By:

Bruzzese, Antonella;
Derudas, Daniele;
Galli, Monica;
Martino, Enrica Antonia;
Rocco, Stefano;
Conticello, Concetta;
Califano, Catello;
Giuliani, Nicola;
Mangiacavalli, Silvia;
Farina, Giuliana;
Lombardo, Alessandra;
Brunori, Marino;
Rossi, Elena;
Antonioli, Elisabetta;
Ria, Roberto;
Zambello, Renato;
Di Renzo, Nicola;
Mele, Giuseppe;
Marcacci, Gianpaolo;
Pietrantuono, Giuseppe

Publication type:

Article

Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 577, doi. 10.1002/hon.3030

By:

Kumari, Sarita;
Ali, M. Shadab;
Singh, Jay;
Arora, Mohit;
Verma, Deepak;
Pandey, Avanish Kumar;
Benjamin, Mercilena;
Bakhshi, Sameer;
Palanichamy, Jayanth Kumar;
Sharma, Atul;
Singh, Inder;
Tanwar, Pranay;
Singh, Amar Ranjan;
Pushpam, Deepam;
Qamar, Imteyaz;
Chopra, Anita

Publication type:

Article

Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 734, doi. 10.1002/hon.3029

By:

Sartor, Chiara;
Arpinati, Mario;
Chirumbolo, Gabriella;
Dozza, Luca;
Cristiano, Gianluca;
Nanni, Jacopo;
Marconi, Giovanni;
Robustelli, Valentina;
Vigliotta, Ilaria;
Parisi, Sarah;
Terragna, Carolina;
Testoni, Nicoletta;
Paolini, Stefania;
Martinelli, Giovanni;
Curti, Antonio;
Cavo, Michele;
Papayannidis, Cristina

Publication type:

Article

Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 609, doi. 10.1002/hon.3028

By:

Rigacci, Luigi;
Battistini, Roberta;
Kovalchuk, Sofia;
Zoli, Valerio;
Puccini, Benedetta;
Evangelista, Andrea;
Arcaini, Luca;
Flenghi, Leonardo;
Visco, Carlo;
Mian, Michael;
Di Rocco, Alice;
Peracchio, Claudia;
Gotti, Manuel;
Tisi, Maria Chiara;
Palombi, Francesca;
Pozzi, Samantha;
Gioia, Daniela;
Viero, Piera;
Martelli, Maurizio

Publication type:

Article

Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 596, doi. 10.1002/hon.3009

By:

Li, Miaomiao;
Yu, Hui;
Qi, Fei;
Ye, Yingying;
Hu, Dingyao;
Cao, Jiaowu;
Wang, Dedao;
Mi, Lan;
Wang, Zhengyi;
Ding, Ning;
Ping, Lingyan;
Shu, Shaokun;
Zhu, Jun

Publication type:

Article

Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 787, doi. 10.1002/hon.3026

By:

Qu, Shiqiang;
Xu, Zefeng;
Qin, Tiejun;
Li, Bing;
Pan, Lijuan;
Chen, Jia;
Yan, Xin;
Wu, Junying;
Zhang, Yudi;
Zhang, Peihong;
Gale, Robert Peter;
Xiao, Zhijian

Publication type:

Article

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 645, doi. 10.1002/hon.3025

By:

Durmo, Rexhep;
Donati, Benedetta;
Rebaud, Louis;
Cottereau, Anne Segolene;
Ruffini, Alessia;
Nizzoli, Maria Elena;
Ciavarella, Sabino;
Vegliante, Maria Carmela;
Nioche, Christophe;
Meignan, Michel;
Merli, Francesco;
Versari, Annibale;
Ciarrocchi, Alessia;
Buvat, Irene;
Luminari, Stefano

Publication type:

Article

Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 716, doi. 10.1002/hon.3024

By:

Lalive d'Epinay, Murielle;
Güsewell, Sabine;
Graf, Nicole;
Mey, Ulrich J. M.;
Driessen, Christoph;
Hitz, Felicitas

Publication type:

Article

The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 567, doi. 10.1002/hon.3005

By:

Wang, Xinchen;
Hu, Maogui;
Yu, Lu;
Wang, Xiaoyan;
Jiang, Xinlu;
Zhang, Guihong;
Ding, Kaiyang

Publication type:

Article

A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 812, doi. 10.1002/hon.2967

By:

Gurnari, Carmelo;
Wahida, Adam;
Pagliuca, Simona;
Durmaz, Arda;
Zawit, Misam;
Haferlach, Torsten;
Maciejewski, Jaroslaw P.;
Visconte, Valeria

Publication type:

Article

Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 505, doi. 10.1002/hon.3013

By:

Bailly, Sarah;
Cartron, Guillaume;
Chaganti, Sridhar;
Córdoba, Raul;
Corradini, Paolo;
Düll, Johannes;
Ferrarini, Isacco;
Osborne, Wendy;
Rosenwald, Andreas;
Sancho, Juan‐Manuel;
Tilly, Hervé;
Van Den Neste, Eric;
Viardot, Andreas;
Visco, Carlo

Publication type:

Article

Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 695, doi. 10.1002/hon.3012

By:

Ailawadhi, Sikander;
Parrondo, Ricardo D.;
Moustafa, Muhamad Alhaj;
LaPlant, Betsy R.;
Alegria, Victoria;
Chapin, Dustin;
Roy, Vivek;
Sher, Taimur;
Paulus, Aneel;
Chanan‐Khan, Asher A.

Publication type:

Article

Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 528, doi. 10.1002/hon.3011

By:

Khan, Sujoy;
Molica, Stefano;
Allsup, David

Publication type:

Article

Reimagining diversity in multiple myeloma clinical trials.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 689, doi. 10.1002/hon.2997

By:

Habr, Dany;
Corsaro, Massimo

Publication type:

Article

B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 658, doi. 10.1002/hon.3008

By:

Gragnani, Laura;
Lorini, Serena;
Marri, Silvia;
Rattotti, Sara;
Madia, Francesco;
Zibellini, Silvia;
Monti, Monica;
Basile, Umberto;
Di Stasio, Enrico;
Libra, Massimo;
Arcaini, Luca;
Zignego, Anna Linda

Publication type:

Article

LncRNA FIRRE stimulates PTBP1‐induced Smurf2 decay, stabilizes B‐cell receptor, and promotes the development of diffuse large B‐cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 554, doi. 10.1002/hon.3004

By:

Liu, Qin‐Hua;
Dai, Guan‐Rong;
Wu, Yi;
Wang, Xiao‐Nan;
Song, Ming‐Yue;
Li, Xiao‐Dan;
Wu, Zhengsheng;
Xia, Rui‐Xiang

Publication type:

Article

Chimeric antigen receptor T‐cell therapy combined with autologous stem cell transplantation improved progression‐free survival of relapsed or refractory diffuse large B‐cell lymphoma patients: A single‐center, retrospective, cohort study

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 637, doi. 10.1002/hon.2975

By:

Wang, Tao;
Xu, Lili;
Gao, Lei;
Tang, Gusheng;
Chen, Li;
Chen, Jie;
Wang, Yang;
Fu, Weijia;
Yue, Wenqin;
Ye, Mingyu;
Yu, Jiechen;
Yu, Xuejun;
Feng, Dongge;
Zhang, Aiping;
Yang, Jianmin

Publication type:

Article

Increased risk of nonrelapse mortality post T‐cell‐replete haploidentical stem cell transplantation in patients with recurrence of acute graft‐versus‐host disease.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 743, doi. 10.1002/hon.2999

By:

Peng, Bo;
Dou, Liping;
Yang, Jingjing;
Wang, Lili;
Li, Fei;
Gao, Xiaoning;
Wang, Shuhong;
Jin, Xiangshu;
Wang, Lu;
Jia, Mingyu;
Wang, Shenyu;
Li, Yan;
Liu, Daihong

Publication type:

Article

High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 541, doi. 10.1002/hon.3003

By:

Hagos, Yeman B.;
Akarca, Ayse U.;
Ramsay, Alan;
Rossi, Riccardo L.;
Pomplun, Sabine;
Ngai, Victoria;
Moioli, Alessia;
Gianatti, Andrea;
Mcnamara, Christopher;
Rambaldi, Alessandro;
Quezada, Sergio A.;
Linch, David;
Gritti, Giuseppe;
Yuan, Yinyin;
Marafioti, Teresa

Publication type:

Article

Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 763, doi. 10.1002/hon.2995

By:

Shumilov, Evgenii;
Hasenkamp, Justin;
Maulhardt, Markus;
Mazzeo, Paolo;
Schmidt, Nicole;
Boyadzhiev, Hristo;
Jung, Wolfram;
Ganster, Christina;
Haase, Detlef;
Koch, Raphael;
Wulf, Gerald

Publication type:

Article

Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 752, doi. 10.1002/hon.2991

By:

Itonaga, Hidehiro;
Kida, Michiko;
Hamamura, Atsushi;
Uchida, Naoyuki;
Ozawa, Yukiyasu;
Fukuda, Takahiro;
Ueda, Yasunori;
Kataoka, Keisuke;
Katayama, Yuta;
Ota, Shuichi;
Matsuoka, Ken‐ichi;
Kondo, Tadakazu;
Eto, Tetsuya;
Kanda, Junya;
Ichinohe, Tatsuo;
Atsuta, Yoshiko;
Miyazaki, Yasushi;
Ishiyama, Ken

Publication type:

Article

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 491, doi. 10.1002/hon.2987

By:

Mughal, Tariq I.;
Pemmaraju, Naveen;
Bejar, Rafael;
Gale, Robert P.;
Bose, Prithviraj;
Kiladjian, Jean‐Jacques;
Prchal, Josef;
Royston, Daniel;
Pollyea, Daniel;
Valent, Peter;
Brümmendorf, Tim H.;
Skorski, Tomasz;
Patnaik, Mrinal;
Santini, Valeria;
Fenaux, Pierre;
Kucine, Nicole;
Verstovsek, Srdan;
Mesa, Ruben;
Barbui, Tiziano;
Saglio, Guiseppe

Publication type:

Article

Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 801, doi. 10.1002/hon.2986

By:

Eichenauer, Dennis A.;
Bühnen, Ina;
Plütschow, Annette;
Kobe, Carsten;
Dietlein, Markus;
Wendtner, Clemens‐Martin;
Thorspecken, Sven;
Topp, Max S.;
Mauser, Mareike;
von Tresckow, Bastian;
Fuchs, Michael;
Borchmann, Peter;
Engert, Andreas

Publication type:

Article

Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 796, doi. 10.1002/hon.2965

By:

Bailly, Clément;
Carlier, Thomas;
Tessoulin, Benoit;
Gastinne, Thomas;
Kraeber‐Bodere, Françoise;
Le Gouill, Steven;
Bodet‐Milin, Caroline

Publication type:

Article

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 809, doi. 10.1002/hon.2960

By:

Tong, Wing H.;
Mesegué, Montserrat;
Dapena, José Luís;
Camós, Mireia;
Rives, Susana

Publication type:

Article

Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 518, doi. 10.1002/hon.2983

By:

Zinzani, Pier Luigi;
Martelli, Maurizio;
Ferrero, S.;
Gentile, Massimo;
Laurenti, Luca;
Romana Mauro, Francesca;
Sportoletti, Paolo;
Tedeschi, Alessandra;
Varettoni, M.;
Visco, Carlo

Publication type:

Article

Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B‐Cell lymphoma ‐results of a single center, retrospective cohort in China.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 617, doi. 10.1002/hon.2979

By:

Wang, Yawen;
Xue, Hongwei;
Song, Wei;
Xiao, Shuxin;
Jing, Fanjing;
Dong, Tieying;
Wang, Lili

Publication type:

Article

Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 667, doi. 10.1002/hon.2977

By:

Miyazaki, Kana;
Suzuki, Ritsuro;
Oguchi, Masahiko;
Taguchi, Senzo;
Amaki, Jun;
Maeda, Takeshi;
Kubota, Nobuko;
Maruyama, Dai;
Terui, Yasuhito;
Sekiguchi, Nodoka;
Takizawa, Jun;
Tsukamoto, Hiroyuki;
Murayama, Tohru;
Ando, Toshihiko;
Matsuoka, Hiroshi;
Hasegawa, Masatoshi;
Wada, Hideho;
Sakai, Rika;
Kameoka, Yoshihiro;
Tsukamoto, Norifumi

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2022, v. 40, n. 4, p. 489, doi. 10.1002/hon.2892
Publication type:: Article

Clinicopathological analysis of immunohistochemical expression of immune checkpoint molecules in follicular lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 530, doi. 10.1002/hon.2972

By:

Yanagida, Eriko;
Miyoshi, Hiroaki;
Takeuchi, Mai;
Shimono, Joji;
Nakashima, Kazutaka;
Yamada, Kyohei;
Kawamoto, Keisuke;
Moritsubo, Mayuko;
Shimasaki, Yasumasa;
Inoue, Kanako;
Imamoto, Teppei;
Furuta, Takuya;
Kohno, Kei;
Ohshima, Koichi

Publication type:

Article